MedPath
HSA Product

PENTAXIM VACCINE

Product approved by Health Sciences Authority (SG)

Basic Information

PENTAXIM VACCINE

INJECTION, POWDER, FOR SUSPENSION

Regulatory Information

SIN14795P

June 5, 2015

Prescription Only

Therapeutic

INTRAMUSCULAR

August 10, 2023

May 30, 2025

XJ07CA06

Company Information

SANOFI-AVENTIS SINGAPORE PTE. LTD.

SANOFI-AVENTIS SINGAPORE PTE. LTD.

Active Ingredients

(Prefilled Syringe) Poliovirus (inactivated) - Type 1 (Mahoney)

Strength: 40 DU/0.5 mL

(Prefilled Syringe) Tetanus toxoid

Strength: min. 40 IU/0.5 mL

(Prefilled Syringe) Diphtheria toxoid

Strength: min. 30 IU/0.5 mL

(Prefilled Syringe) Poliovirus (inactivated) - Type 2 (MEF-1)

Strength: 8 DU/0.5 mL

(Vial) Tetanus protein (PRP-T)

Strength: 18 - 30 μg/0.5 mL

Detailed Information

Contraindications

**4.3 Contraindications** - Hypersensitivity: - to one of the active substances of PENTAXIM, - to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_, - glutaraldehyde, neomycin, streptomycin, or polymyxin B (used during manufacturing, and which may be present in trace amounts), - pertussis vaccine (acellular or “whole cell”). - Severe reaction after a previous injection of the vaccine or a vaccine containing the same substances. - Vaccination should be postponed in case of fever or acute illness. - Progressive encephalopathies. - Encephalopathy within 7 days of a previous dose of any vaccine containing pertussis antigens (“whole cell” or acellular pertussis vaccine).

Indication Information

**4.1 Therapeutic Indications** PENTAXIM (DTaP-IPV-Hib) is indicated for the joint prevention of diphtheria, tetanus, pertussis, poliomyelitis and invasive _Haemophilus influenzae_ type b infections (meningitis, septicaemia, cellulitis, arthritis, epiglottitis, etc.,), - for primary vaccination in infants from the age of 2 months, - for booster vaccination, one year after primary vaccination during the second year of life. This vaccine does not protect against infections caused by the other types of _Haemophilus influenzae_ nor against meningitis caused by other micro-organisms.

© Copyright 2025. All Rights Reserved by MedPath